CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCell–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M….
Author: Business Wire
Midwest Vision Partners Announces Partnership With Eye Centers of Ohio
CHICAGO & CANTON, OHIO–(BUSINESS WIRE)– #eyecare–Midwest Vision Partners Announces Partnership With Eye Centers of Ohio
Resumen: El CHMP recomienda la aprobación en la UE de Enspryng (satralizumab) de Chugai para el trastorno del espectro de la neuromielitis óptica (TENMO)
TOKIO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) ha anunciado hoy que Roche ha recibido la notificación de que el Comité de Medicamentos de Uso Humano (CHMP en sus siglas en inglés) de la Agencia Europea del Medicamento (EMA) ha re…
CHMP 建議歐盟核准將中外製藥的Enspryng (Satralizumab)用於治療泛視神經脊髓炎(NMOSD)
東京–(BUSINESS WIRE)–(美國商業資訊)–中外製藥株式會社(Chugai Pharmaceutical Co., Ltd., TOKYO:4519)今天宣布，羅氏(Roche)已收到通知指出，歐洲藥品管理局(EMA)人用藥品委員會(CHMP)建議核准中外製藥研製的pH依賴型結合人源化抗IL-6受體單株抗體Enspryng® (satralizumab)，將其作為抗水通道蛋白-4抗體(AQP4-IgG)血清陽性的成人及12歲以上青少年泛視神經脊髓炎(NMOSD)患者的首個皮下治療選…
Samenvatting: CHMP beveelt EU-goedkeuring aan van Chugai’s Enspryng (Satralizumab) voor Neuromyelitis Optica Spectrum Disorder (NMOSD)
TOKIO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) heeft vandaag aangekondigd dat Roche een kennisgeving heeft ontvangen dat het Committee for Medicinal Products for Human Use (CHMP) van het European Medicines Agency’s (EMA) de goedk…
Riassunto: Il CHMP raccomanda l’approvazione da parte della UE di Enspryng (satralizumab) di Chugai per il disturbo dello spettro della neuromielite ottica (Neuromyelitis Optica Spectrum Disorder, NMOSD)
TOKYO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) ha annunciato oggi che Roche ha ricevuto la notifica che il Comitato per i medicinali per uso umano (Committee for Medicinal Products for Human Use, CHMP) dell’Agenzia europea per i m…
CHMP Recommends EU Approval of Chugai’s Enspryng (Satralizumab) for Neuromyelitis Optica Spectrum Disorder (NMOSD)
TOKYO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that Roche has received notification that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of t…
Bollé Safety biedt nu Trivex-lenzen voor haar veiligheidsbrillen op sterkte
VILLEURBANNE, Frankrijk–(BUSINESS WIRE)–Wereldwijde oogbeschermingsspecialist Bollé Safety biedt nu Trivex aan. Een hoogwaardige, hoogtechnologische lens op sterkte die maximale veiligheid en uitstekende optische eigenschappen biedt om de beste veili…
jCyte Inc. Announces Presentations at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–jCyte Inc. Announces Presentations at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Midwest Vision Partners Announces Partnerships With Premier Ophthalmology Groups in Greater Detroit
CHICAGO & BLOOMFIELD HILLS, Mich. & WARREN, Mich. & TROY, Mich.–(BUSINESS WIRE)– #eyecare–Midwest Vision Partners (“MVP”), a people-focused eye care management services organization, is excited to announce partnerships with Grosinger, Spigelman, &am…
Change Healthcare Launches InterQual® 2021 Solution Providing Guidance on Telehealth, Social Determinants of Health, and the Testing and Treatment of COVID-19 Patients
NASHVILLE, Tenn.–(BUSINESS WIRE)– #analytics–Change Healthcare Launches InterQual 2021 Solution Providing Guidance on Telehealth, SDoH, and the Testing and Treatment of COVID-19 Patients
STAAR Surgical to Report First Quarter Results on May 5, 2021
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the…
Global Acute Ocular Pain Epidemiology Forecast to 2030: Focus on United States, Germany, France, Italy, Spain, United Kingdom and Japan – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Acute Ocular Pain – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. This ‘Acute Ocular Pain (AOP) – Epidemiology Forecast-2030’ report delivers an in-depth understanding of the AO…
Bollé Safety ora offre su richiesta Trivex per le sue lenti di sicurezza correttive
VILLEURBANNE, Francia–(BUSINESS WIRE)–Bollé Safety, leader mondiale nel design e nella produzione di occhiali protettivi, ora offre lenti correttive prodotte con Trivex. Un materiale di alta tecnologia, dalle prestazioni elevate che garantisce la mas…
Bollé Safety ofrece ahora lentes de seguridad graduadas con el material Trivex
VILLEURBANNE, Francia–(BUSINESS WIRE)–Bollé Safety, el especialista mundial en protección ocular, incluye ahora el material Trivex en su gama de gafas graduadas de seguridad. Una lente graduada de alto rendimiento y alta tecnología que proporciona la…
Bollé Safety bietet ab sofort Schutzbrillen mit Trivex-Korrekturgläsern an
VILLEURBANNE, Frankreich–(BUSINESS WIRE)–Der weltweit tätige Augenschutzspezialist Bollé Safety bietet jetzt auch Brillen mit Trivex-Glas an. Trivex ist ein sehr leistungsfähiges High-Tech-Korrekturglas, das maximale Sicherheit und hervorragende opti…
National Vision Welcomes Roger Francis as Chief Stores Officer, Announces Planned Retirement of Sharon Petitt
DULUTH, Ga.–(BUSINESS WIRE)—- $EYE #leadership–National Vision Holdings, Inc. (NASDAQ: EYE), one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, today announced the selection of Roger Francis as Chief S…
Protezione avanzata degli occhi contro il Covid-19 per gli operatori sanitari – una tecnologia esclusiva di Bollé Safety
VILLEURBANNE, Francia–(BUSINESS WIRE)–Bollé Safety, leader mondiale nel design e nella produzione di occhiali protettivi, presenta la sua divisione Healthcare dedicata a tutti i professionisti sanitari. La sua gamma di occhiali protettivi con rivesti…
Geavanceerde oogbescherming tegen Covid-19 voor zorgverleners – een exclusieve technologie van Bollé Safety
VILLEURBANNE, Frankrijk–(BUSINESS WIRE)–Bollé Safety, wereldleider in het ontwikkelen en de produceren van veiligheidsbrillen, presenteert haar Healthcare-divisie, toegewijd aan alle zorgprofessionals. Het assortiment beschermende brillen met PLATINU…
Bollé Safety présente sa gamme de protection oculaire à destination des professionnels de santé – une technologie exclusive de Bollé Safety
VILLEURBANNE, France–(BUSINESS WIRE)–Bollé Safety, leader mondial dans la conception et la fabrication de lunettes de protection, présente sa division Healthcare dédiée à tous les professionnels de santé. Sa gamme de lunettes et masques de protection…